학술논문
A randomised phase III multicentre trial to evaluate the duration of anti-PD1 monoclonal antibody monotherapy in patients with metastatic melanoma (DANTE) - Stage 1 Results
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15321827